4174.TWO
Price:
$28.85
Market Cap:
$7.59B
OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology drug; OBI-888, a passive immunotherapy monoclonal antibody designed for targeting Globo H; OBI-999, an antibody drug conjugate; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a botulinum toxin, as well as OBI-898 and OBI-998 drugs. The company was founded in...[Read more]
Industry
Biotechnology
IPO Date
2012-12-12
Stock Exchange
TWO
Ticker
4174.TWO
According to OBI Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.54. This represents a change of -33.27% compared to the average of 9.80 of the last 4 quarters.
The mean historical Current Ratio of OBI Pharma, Inc. over the last ten years is 26.25. The current 6.54 Current Ratio has changed 2.39% with respect to the historical average. Over the past ten years (40 quarters), 4174.TWO's Current Ratio was at its highest in in the June 2017 quarter at 169.70. The Current Ratio was at its lowest in in the June 2025 quarter at 6.54.
Average
26.25
Median
21.34
Minimum
8.34
Maximum
68.66
Discovering the peaks and valleys of OBI Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 160.99%
Maximum Annual Current Ratio = 68.66
Minimum Annual Increase = -58.13%
Minimum Annual Current Ratio = 8.34
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 8.34 | -58.13% |
| 2023 | 19.92 | -12.48% |
| 2022 | 22.76 | 160.99% |
| 2021 | 8.72 | -44.35% |
| 2020 | 15.67 | -33.39% |
| 2019 | 23.53 | -35.60% |
| 2018 | 36.54 | -46.78% |
| 2017 | 68.66 | 72.47% |
| 2016 | 39.81 | 114.38% |
| 2015 | 18.57 | -12.36% |
The current Current Ratio of OBI Pharma, Inc. (4174.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.01
5-year avg
15.08
10-year avg
26.25
OBI Pharma, Inc.’s Current Ratio is less than Formosa Pharmaceuticals, Inc. (9.85), less than TaiGen Biopharmaceuticals Holdings Limited (12.81), less than Pharmosa Biopharm Inc. (14.27), greater than BRIM Biotechnology, Inc. (5.18), greater than Mycenax Biotech Inc. (0.84), less than CHO Pharma, Inc. (21.85), less than Savior Lifetec Corporation (8.88), greater than Sinphar Pharmaceutical Co.,Ltd. (2.07), greater than Panion & Bf Biotech Inc. (1.32), greater than PharmaEngine, Inc. (5.38),
| Company | Current Ratio | Market cap |
|---|---|---|
| 9.85 | $4.23B | |
| 12.81 | $8.08B | |
| 14.27 | $6.94B | |
| 5.18 | $3.70B | |
| 0.84 | $6.73B | |
| 21.85 | $6.37B | |
| 8.88 | $5.65B | |
| 2.07 | $5.82B | |
| 1.32 | $5.70B | |
| 5.38 | $10.40B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OBI Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OBI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is OBI Pharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for OBI Pharma, Inc. (4174.TWO)?
What is the highest Current Ratio for OBI Pharma, Inc. (4174.TWO)?
What is the 3-year average Current Ratio for OBI Pharma, Inc. (4174.TWO)?
What is the 5-year average Current Ratio for OBI Pharma, Inc. (4174.TWO)?
How does the current Current Ratio for OBI Pharma, Inc. (4174.TWO) compare to its historical average?